Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

CANCER VACCINES

An optimized antigen–protein fusion

The fusion of an immunogenic peptide and the protein transthyretin protects the peptide antigen from proteolytic degradation, optimizes its uptake in local draining lymphatics and reduces its presentation in uninflamed distal lymphoid organs, as shown in mice.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: Optimized antigen–protein fusion for efficient vaccination.

References

  1. Rammensee, H. G., Falk, K. & Rotzschke, O. Annu. Rev. Immunol. 11, 213–244 (1993).

    CAS  Article  Google Scholar 

  2. Toes, R. E., Offringa, R., Blom, R. J., Melief, C. J. & Kast, W. M. Proc. Natl Acad. Sci. USA 93, 7855–7860 (1996).

    CAS  Article  Google Scholar 

  3. Mehta, N. K. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-020-0563-4 (2020).

  4. Francis, M. J. et al. Proc. Natl Acad. Sci. USA 87, 2545–2549 (1990).

    CAS  Article  Google Scholar 

  5. Janssen, R. & Tommassen, J. Int. Rev. Immunol. 11, 113–121 (1994).

    CAS  Article  Google Scholar 

  6. Suzue, K. & Young, R. A. J. Immunol. 156, 873–879 (1996).

    CAS  PubMed  Google Scholar 

  7. Mu, X. et al. J. Virol. Methods 228, 84–90 (2016).

    CAS  Article  Google Scholar 

  8. Botelho, N. K. et al. Front. Immunol. 10, 294 (2019).

    CAS  Article  Google Scholar 

  9. Ishihara, J. et al. Sci. Transl. Med. 9, eaan0401 (2017).

    Article  Google Scholar 

  10. Wille-Reece, U. et al. Proc. Natl Acad. Sci. USA 102, 15190–15194 (2005).

    CAS  Article  Google Scholar 

  11. Zom, G. G., Khan, S., Filippov, D. V. & Ossendorp, F. Adv. Immunol. 114, 177–201 (2012).

    CAS  Article  Google Scholar 

  12. Kim, S. et al. Nat. Rev. Mater. 4, 355–378 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pedro Romero.

Ethics declarations

Competing interests

P.R. is a member of the scientific advisory board of immatics biotechnologies GmbH. J.A.H. is co-founder of Arrow Immune, Inc., and through his university holds patents in immuno-oncology. The remaining author declares no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Romero, P., Donda, A. & Hubbell, J.A. An optimized antigen–protein fusion. Nat Biomed Eng 4, 583–584 (2020). https://doi.org/10.1038/s41551-020-0572-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-020-0572-3

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing